Neurocutaneous Syndromes D020752

Related MeSH Hierarchy (6)

Diseases [C] » Nervous System Diseases [C10] » Neurocutaneous Syndromes

Diseases [C] » Skin and Connective Tissue Diseases [C17] » Skin Diseases » Skin Abnormalities » Ectodermal Dysplasia » Neurocutaneous Syndromes

Diseases [C] » Skin and Connective Tissue Diseases [C17] » Skin Diseases » Skin Diseases, Genetic » Ectodermal Dysplasia » Neurocutaneous Syndromes

Description

A group of disorders characterized by ectodermal-based malformations and neoplastic growths in the skin, nervous system, and other organs.   MeSH

Subtype Terms (6)

Ataxia Telangiectasia
28 drugs (25 approved, 3 experimental)

Neurofibromatoses
16 drugs (14 approved, 2 experimental)

Nevus, Sebaceous of Jadassohn
 

Sturge-Weber Syndrome
5 drugs (4 approved, 1 experimental)

Tuberous Sclerosis
13 drugs (9 approved, 4 experimental)

von Hippel-Lindau Disease
18 drugs (13 approved, 5 experimental)

Hierarchy Tree View

UMLS Data


YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.